Cellectar secures 'extended partnership' to support clinical trial needs

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/shironosov)
(Image: iStock/shironosov)

Related tags: Clinical trial

Cellectar Biosciences has announced a partnership with the Centre for Probe Development and Commercialization (CPDC) to establish manufacturing capacity ahead of the company’s NCI-supported Ph II trial of CLR 131.

Per the agreement, the GMP manufacturing organization, which specializes in radiopharmaceuticals, will serve as a supplier of Cellectar’s lead phospholipid drug conjugate (PDC), CLR 131.

CPDC possesses a great team and extensive experience manufacturing radiotherapeutics​,” Jim Caruso, president and CEO of Cellectar Biosciences, told us, adding that the company will provide “cost effective, high quality finished product manufacturing for the long term​.”

This partnership will provide additional supply of CLR 131 and insure sufficient manufacturing capacity to support Cellectar’s near term clinical trial needs as well as pivotal study and larger scale commercialization requirements​,” he added.

When asked how long the partnership is set to last, Caruso said “Cellectar looks forward to an extended partnership with CPDC​.”

The next steps for the partnership include ongoing process integration and enhancement.

Related news

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more